Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2014

Feb 6, 2014

6990_dirs_2014-02-06_2f92707f-402c-406f-807d-0e697669063d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2014-02-04

Reporting Person: Gur-Lavie Boaz (CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-04 Common Stock A 27500 Acquired 54500 Direct

Footnotes

F1: The shares vest as follows: 5,000 shares - 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter. 22,500 shares will be vested upon goals achievement.